Per Antonsson

The future of building planning. Register to become one of our first users.

Paindrainer AB is a Swedish company founded in 2018 by an experienced entrepreneur (Carl Borrebaeck), a software architect (Göran Barkfors) and an academic graduate highly proficient in pain therapies (Maria Klement). The aim of the company is to address the healthcare problem costing the society more in total than heart disease, cancer and diabetes combined – chronic pain. Paindrainer AB aim to deliver a disruptive tool based on advanced Artificial Intelligent algorithms that will meet the urgent clinical need for a novel treatment of chronic and non-malignant pain. Our product - Paindrainer is the first drug-free, self-management coach allowing identification of each patient’s pain triggers and pain protectors. In that way, Paindrainer makes it possible for each patient to achieve a maximum level of function at the lowest possible level of pain. To bring our innovation to the market, we have gathered a team that is characterized by a diversity of business, technical and academic experience.

Aligned Bio is a nanotechnology company whose simple and quick single molecule detection capability will have positive impact on the DNA sequencing and biomarker detection industry. Please visit www.alignedbio.com for more information.

A better day starts with taking back control of your night. Learning to sleep offers clinically proven sleep improvement programs for people with sleeping disorder through web and mobile solutions.

Amniotics was born out of the discovery of novel stem cells in full term amniotic fluid. Research on these cells has demonstrated a number of unique properties in them, highlighting their extraordinary suitability for medical applications. These properties, in combination with safe collection, ethical agreeability, tissues and high cell counts harbour the promise of the exciting journey we have started pushing medical boundaries. The science and research behind the discoveries on which the company is based has been carried out within the realms of the reputable Lund University in southern Sweden, one of its prime research centers BMC (Bio Medical Center) Research Center, and the university hospital in Lund. Therefore, Amniotics considers itself today to be uniquely positioned to translate stem cell technologies into novel and improved human therapeutics. Our ultimate vision is to contribute to the successful treatment of serious human diseases by providing the very best cells for various regenerative medical applications. The fact that our cells are of neonatal source (and safely retrieved from the amniotic fluid from C-sections), means that they have greater genome integrity. And also other positive attributes of the neonatal source of our cells makes them superior to traditional sources of stem cells that are currently in therapeutic use. As part of our commitment to providing the best cell therapeutics we are developing these for treatments with high unmet needs in collaboration with international renowned KOLs and partners. In a nutshell, we have designed and built a complete ecosystem for managing these cells in a safe, secure and controlled manner, which we are now expanding and scaling up. Our journey continues. We will push the boundaries of science within regenerative medicine to save and improve the lives of many. #regenerativemedicine, #stemcells #therapies

Nattaro Labs AB is focused on effective, proprietary solutions for the eradication of bedbugs using cutting-edge knowledge in prevention, detection and control of infestations using new non-toxic techniques. Nattaro Labs unique experience in bed bug research, chemical ecology, and insect behavior positions us as leading edge experts in delivering broadly marketable, valuable solutions for the rapidly growing, worldwide bed bug infestation problem. Our unique experience in bed bug research, positions us as one of the world-leading experts in bed bug chemical ecology and behaviour with cutting-edge knowledge in how to successfully prevent, detect and control bed bug infestations by using new non-toxic techniques, giving us the prospect of becoming a major player. Our target groups are, besides the pest control professionals, the industries most affected by infestations, primarily Hotels and other Accommodation providers in the Travel industry. Nattaro Labs business idea, being experts on the subject, is to develop and provide solutions with which our customers will be able to effectively detect, control and prevent bed bug infestations. Our products will be environmentally sustainable and based on extensive and advanced research on pheromones and kairomones, i.e. chemical cues essential for orientation in bed bugs. A unique strength is also our laboratory with a bed bug culture, on which the products are tested on live bed bugs. We will provide the market with alternative strategies and tools to be used to handle bed bug infestations; i.e. Prevention, detection and control.

Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge, in the absence of itching. Standard treatment consists of antimicrobials, but recurrence rate is15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation’s top ten threats to global health in 2021 and research into novel non-antimicrobial based treatments is timely.

LU Ventures, previously known as LU Holding, is Lund Universitys dedicated venture builder. We collaborate with researchers to transform cutting-edge discoveries into innovative products and services, bridging the gap between academic research and market applications. Our comprehensive support has nurtured over 140 startups to date, which have collectively raised more than 11.8 billion SEK in venture capital. To learn more about our mission and success stories, please visit our website: https://www.innovation.lu.se/en/lu-ventures

The future of building planning. Register to become one of our first users.

Paindrainer AB is a Swedish company founded in 2018 by an experienced entrepreneur (Carl Borrebaeck), a software architect (Göran Barkfors) and an academic graduate highly proficient in pain therapies (Maria Klement). The aim of the company is to address the healthcare problem costing the society more in total than heart disease, cancer and diabetes combined – chronic pain. Paindrainer AB aim to deliver a disruptive tool based on advanced Artificial Intelligent algorithms that will meet the urgent clinical need for a novel treatment of chronic and non-malignant pain. Our product - Paindrainer is the first drug-free, self-management coach allowing identification of each patient’s pain triggers and pain protectors. In that way, Paindrainer makes it possible for each patient to achieve a maximum level of function at the lowest possible level of pain. To bring our innovation to the market, we have gathered a team that is characterized by a diversity of business, technical and academic experience.

Aligned Bio is a nanotechnology company whose simple and quick single molecule detection capability will have positive impact on the DNA sequencing and biomarker detection industry. Please visit www.alignedbio.com for more information.

A better day starts with taking back control of your night. Learning to sleep offers clinically proven sleep improvement programs for people with sleeping disorder through web and mobile solutions.